Logo_Luminex
WHITE PAPERS

xMAP® Multiplex Assays Enable HIV Research

xmap-multiplex-assays-enable-hiv-research_whitepaper_life-science-research_luminex-corp_v3

Unlock Insights with our White Papers.

Dive deeper into industry trends, research, and gain valuable knowledge.

Get the latest data and expert insights at your fingertips. Discover, learn, and stay ahead in your field.

As the causative agent of the acquired immune deficiency syndrome (AIDS) pandemic, HIV has been the focus of intense research for more than 30 years.

In this overview of peer-reviewed literature you’ll find:

How multiplex assays are essential to HIV research for detecting antibodies in response to HIV infection and biomarkers in response to HIV infection
How vaccine development and the search for broadly Neutralizing antibodies has been aided by multiplexed assay
Progress in estimation of HIV-1 incidence by multiplex antibody detection
The role of inflammatory cytokines in HIV infection - The first few weeks following HIV-1 infection are characterized by a cytokine storm immune response in the plasma, in which levels of multiple cytokines rise rapidly
The relationship between tuberculosis (TB) and immune reconstitution inflammatory syndrome - HIV-1 infected individuals face a dual epidemic of TB and HIV
A partial list of institutions using multiplex assays to accelerate their HIV-focused research

Download the White Paper

diasorin-logo-1-2

 

Follow us

.  

Document Repository
Diasorin Immuno and Molecular product documentationDialog

Licensed Technologies and Luminex productsProduct documentation